Transactions in connection with share buy-back program

Company Announcement
COPENHAGEN, Denmark; June 28, 2021 Genmab A/S (Nasdaq: GMAB). On February 23, 2021 Genmab announced the initiation of a share buy-back program to mitigate dilution from warrant exercises and to honor our commitments under our Restricted…

Click here to view the original article.